Amarin stock was absolutely crushed at the tail end of March, and now the company is dealing with the fallout. Investors will be asking a lot of tough questions. Namely, is Amarin…
Co-Diagnostics is on many shortlists of companies with partial medical solutions to slow the coronavirus outbreak. Investors have been on a roller-coaster ride. Is the stock ready to run?
Thursday's top analyst upgrades, downgrades and initiations included Barrick Gold, BlackRock, Comcast, Microsoft, NextEra Energy, Ping, Shopify, Tesla, 3D Systems and UnitedHealth.
Thursday's top analyst upgrades, downgrades and initiations included Advanced Micro Devices, Applied Materials, Carnival, Dell, Karuna Therapeutics, Lowe's, Noble Energy, PayPal, Square, Target and Virgin Galactic.
Mylan is scheduled to release its first-quarter financial results before the markets open on Tuesday, and earnings are expected to be lower than a year ago.
With low volatility ratings, big dividends and some growth potential, these five stocks are ideal for investors looking for something they can add to their portfolios and forget about.
The top analyst upgrades, downgrades and initiations seen on Friday included Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, United Technologies and Zillow.
More and more branded drugs seem to be facing generic competition. The impact might not be so positive for Big Pharma giants, but this can be a serious victory for consumers and…
Pfizer is scheduled to release its fourth-quarter financial results before the markets open on Tuesday. Consensus estimates call for modest year-over-year growth.
GlaxoSmithKline shares bounced higher on Wednesday after the company announced a new joint venture with Pfizer. These two firms will create a premier global consumer health care company combining their robust iconic…
Elon Musk previews Los Angeles transportation tunnel, Pfizer and GlaxoSmithKline team up, stock buybacks hit a record this year, and other important business headlines today.
Douglas A. McIntyre The top analyst upgrades, downgrades and initiations seen on Friday included Activision Blizzard, BioMarin Pharmaceuticals, Ciena, Delta Air Lines, GlaxoSmithKline, Procter & Gamble, Regeneron and Tesla.
The top analyst upgrades, downgrades and initiations seen on Thursday included Alphabet, American Water, Apple, Facebook, Macy's, Southern Copper, Twitter and YY.
Tesaro shares absolutely exploded early on Monday after the company announced that it has entered a definitive agreement to be acquired by GlaxoSmithKline.
Chris Lange Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
